Morgan Stanley provided market analysis on the Colgate-Palmolive Company on July 25, 2026.
3 reports, 1 independent
Updated Aug 27
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley provided market analysis on the Colgate-Palmolive Company on July 25, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Morgan Stanley
U.S. investment bank
-
Colgate-Palmolive Company
American multinational consumer products company
Nothing else this week.
Related events
- Both Morgan Stanley and State Street are identified as major financial institutions.
- Morgan Stanley strategist Wilson provided a market assessment covering investor positioning and bond yields.
- Morgan Stanley and Carlyle Group released research reports and price targets for a company whose stock trades on the Nasdaq platform.
- Morgan Stanley announced its backing of the medical device manufacturer Sahajanand Medical Technologies Limited.
- Colgate-Palmolive Company disclosed financial filings to the SEC, and CEO Noel Wallace sold company stock.
Coverage
Newest first; wire copies grouped- dailypolitical.comMorningstar Investment Management LLC Has $5.54 Million Stake in Colgate-Palmolive Company $CL